Vice President of Sales and Marketing, Yaron Silberman, to Present at the Inventors Corner Session on January 4, 2017 at 5:50pm IST
Live Procedure in Germany Highlights Benefits and Ease-of-Use of MUSE™ to Top Endoscopists in Europe; Renowned gastroenterologists, Professors Messmann and Neuhaus, demonstrate transoral fundoplication with Medigus’ MUSE at Endo-Update in Germany
Medigus today announced the completion of a live transoral fundoplication (TF) procedure using the Medigus Ultrasonic Surgical Endostapler (MUSE™) system.
Medigus Ltd. today announced that it has entered into a definitive agreement with institutional investors providing for the issuance of 1,139,170 American depositary shares (ADS) at a purchase price per ADS of $0.67 in a registered direct offering.
Medigus Announces a Notice of Intention to Grant a European Patent for Its micro ScoutCam™ Microvisual Technology
Medigus Ltd. announced today that it has received a Notice of Intention to Grant a Patent from the European Patent Office (EPO) for its micro ScoutCam™ miniature camera technology.
Medigus Ltd. today announced financial results for the third quarter ended September 30, 2016.
Medigus entered into definitive securities purchase agreements with two institutional investors.
Medigus Ltd. today announced financial results for the second quarter ended June 30, 2016.
World renowned healthcare institution purchases its first MUSE console and device to offer GERD patients a minimally-invasive treatment option
Innovative technology allows physicians to perform transoral fundoplication for effective, long-term treatment of acid reflux and improve patients’ GERD-related quality of life